Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64,240 ILa | +0.58% |
|
+4.66% | -11.39% |
06-14 | Morgan Stanley Adjusts Price Target on NICE to $240 From $290, Maintains Overweight Rating | MT |
06-12 | RBC Capital Cuts Price Target on NICE to $230 From $265, Maintains Outperform Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.39% | 10.75B | |
+22.35% | 3,414B | |
+18.38% | 93.41B | |
+16.74% | 86.85B | |
+51.06% | 57.52B | |
-20.29% | 48.67B | |
+37.81% | 48.1B | |
-23.45% | 47.45B | |
+76.52% | 40.4B | |
-4.57% | 27.06B |
- Stock Market
- Equities
- NICE Stock
- News NICE Ltd.
- Transcript : NICE Ltd., Q3 2023 Earnings Call, Nov 16, 2023